Expression of activator protein-1 (AP-1) family members in breast cancer

[1] Parkin DM(2005)Global cancer statistics, 2002 CA Canc J Clin 55 74-108

[2] Bray F(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 10869-10874

[3] Ferlay J(2008)The cancer biomarker problem Nature 452 548-552

[4] Pisani P(1995)Progesterone and estrogen receptors and mammary neoplasia in the Iowa women's health study: how many kinds of breast cancer are there? Canc Epidemiol Biomarkers Prev 4 319-326

[5] Sorlie T(2001)Testing for HER2 status Oncology 61 22-30

[6] Perou CM(2010)Current and emerging biomarkers in breast cancer: prognosis and prediction Endocr Relat Canc 17 R245-R262

[7] Tibshirani R(2002)Endocrine-responsive breast cancer and strategies for combating resistance Nat Rev Canc 2 101-112

[8] Aas T(1993)Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk Epidemiol Rev 15 17-35

[9] Geisler S(2000)Hormone-related Factors and Risk of Breast Cancer in Relation to Estrogen Receptor and Progesterone Receptor Status Am J Epidemiol 151 703-714

[10] Johnsen H(2006)International Union of Pharmacology. LXIV. Estrogen receptors Pharmacol Rev 58 773-781

[1] Parkin DM(2005)Global cancer statistics, 2002 CA Canc J Clin 55 74-108

[2] Bray F(2001)Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 10869-10874

[3] Ferlay J(2008)The cancer biomarker problem Nature 452 548-552

[4] Pisani P(1995)Progesterone and estrogen receptors and mammary neoplasia in the Iowa women's health study: how many kinds of breast cancer are there? Canc Epidemiol Biomarkers Prev 4 319-326

[5] Sorlie T(2001)Testing for HER2 status Oncology 61 22-30

[6] Perou CM(2010)Current and emerging biomarkers in breast cancer: prognosis and prediction Endocr Relat Canc 17 R245-R262

[7] Tibshirani R(2002)Endocrine-responsive breast cancer and strategies for combating resistance Nat Rev Canc 2 101-112

[8] Aas T(1993)Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk Epidemiol Rev 15 17-35

[9] Geisler S(2000)Hormone-related Factors and Risk of Breast Cancer in Relation to Estrogen Receptor and Progesterone Receptor Status Am J Epidemiol 151 703-714

[10] Johnsen H(2006)International Union of Pharmacology. LXIV. Estrogen receptors Pharmacol Rev 58 773-781